What's new

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Status: Authorised

Feb 11, 2025 - 14:09
 0
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Status: Authorised
Read More

Tags:

Previous Article

On the Ground with Grocery Stores Ditching Plastic

Next Article

HiteJinro makes foreign distillery debut with Vietnam move

Related Posts

Summary of opinion: Abrysvo, 27/02/2025 Positive

Summary of opinion: Abrysvo, 27/02/2025 Positive

Feb 28, 2025  0

EMEA-001619-PIP03-16-M02

EMEA-001619-PIP03-16-M02

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0